These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 6810900
1. Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo. Brodie AM, Brodie HJ, Garrett WM, Hendrickson JR, Marsh DA, Tsai-Morris CH. Biochem Pharmacol; 1982 Jun 01; 31(11):2017-23. PubMed ID: 6810900 [Abstract] [Full Text] [Related]
2. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model. Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH. Cancer Res; 1982 Aug 01; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949 [Abstract] [Full Text] [Related]
3. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors. Wing LY, Garrett WM, Brodie AM. Cancer Res; 1985 Jun 01; 45(6):2425-8. PubMed ID: 3921242 [Abstract] [Full Text] [Related]
4. Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione. Brodie AM, Marsh D, Brodie HJ. J Steroid Biochem; 1979 Apr 01; 10(4):423-9. PubMed ID: 109701 [No Abstract] [Full Text] [Related]
5. Antifertility effects of an aromatase inhibitor, 1,4,6-androstatriene-3, 17-dione. Brodie AM, Wu JT, Marsh DA, Brodie HJ. Endocrinology; 1979 Jan 01; 104(1):118-21. PubMed ID: 446339 [Abstract] [Full Text] [Related]
6. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors. De Coster R, Van Ginckel RF, Callens MJ, Goeminne NK, Janssens BL. Cancer Res; 1992 Mar 01; 52(5):1240-4. PubMed ID: 1737385 [Abstract] [Full Text] [Related]
7. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors. Zaccheo T, Giudici D, Lombardi P, di Salle E. Cancer Chemother Pharmacol; 1989 Mar 01; 23(1):47-50. PubMed ID: 2491793 [Abstract] [Full Text] [Related]
8. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors. Abul-Hajj YJ. J Steroid Biochem; 1989 Mar 01; 34(1-6):439-42. PubMed ID: 2516585 [Abstract] [Full Text] [Related]
9. Inhibition of aromatization stimulates luteinizing hormone and testosterone secretion in adult male rhesus monkeys. Ellinwood WE, Hess DL, Roselli CE, Spies HG, Resko JA. J Clin Endocrinol Metab; 1984 Dec 01; 59(6):1088-96. PubMed ID: 6541658 [Abstract] [Full Text] [Related]
10. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors. Nishino Y, Schneider MR, Michna H, el Etreby MF. J Steroid Biochem; 1989 Dec 01; 34(1-6):435-7. PubMed ID: 2533949 [Abstract] [Full Text] [Related]
11. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat. Yamamoto T, Urabe M, Tamura T, Kitawaki J, Honjo H, Okada H. Anticancer Res; 1991 Dec 01; 11(6):1999-2002. PubMed ID: 1776832 [Abstract] [Full Text] [Related]
12. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. Brueggemeier RW, Li PK. Cancer Res; 1988 Dec 01; 48(23):6808-10. PubMed ID: 3141048 [Abstract] [Full Text] [Related]
13. Inhibition of ovarian aromatase by prolactin in vivo. Tsai-Morris CH, Ghosh M, Hirshfield AN, Wise PM, Brodie AM. Biol Reprod; 1983 Sep 01; 29(2):342-6. PubMed ID: 6685537 [Abstract] [Full Text] [Related]
15. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Brodie AM, Schwarzel WC, Shaikh AA, Brodie HJ. Endocrinology; 1977 Jun 01; 100(6):1684-95. PubMed ID: 404132 [Abstract] [Full Text] [Related]
16. Differential responses of sex steroid target tissues of rats treated with 4-hydroxyandrostenedione. Wing LY, Hammond JO, Brodie AM. Endocrinology; 1988 Jun 01; 122(6):2418-27. PubMed ID: 3131115 [Abstract] [Full Text] [Related]
17. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function. Zelinski-Wooten MB, Hess DL, Baughman WL, Molskness TA, Wolf DP, Stouffer RL. J Clin Endocrinol Metab; 1993 Apr 01; 76(4):988-95. PubMed ID: 8473415 [Abstract] [Full Text] [Related]
18. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. Schieweck K, Bhatnagar AS, Batzl C, Lang M. J Steroid Biochem Mol Biol; 1993 Mar 01; 44(4-6):633-6. PubMed ID: 8476774 [Abstract] [Full Text] [Related]
19. Effect of an inhibitor of aromatization, 1,4,6 androstatriene-3,17-dione (ATD) on LH release and steroid binding in hypothalamus of adult female rats. Slama A, Gogan F, Sarrieau A, Vial M, Rostene W, Kordon C. Exp Brain Res; 1986 Mar 01; 64(3):407-10. PubMed ID: 3803480 [Abstract] [Full Text] [Related]
20. Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours. Zaccheo T, Giudici D, Ornati G, Panzeri A, di Salle E. Eur J Cancer; 1991 Mar 01; 27(9):1145-50. PubMed ID: 1835626 [Abstract] [Full Text] [Related] Page: [Next] [New Search]